4-(2-methyl-1,3-oxazol-5-yl)benzenesulfonyl chloride
|
- $367 - $1467
- Product name: 4-(2-methyl-1,3-oxazol-5-yl)benzenesulfonyl chloride
- CAS: 293306-72-6
- MF: C10H8ClNO3S
- MW: 257.69
- EINECS:
- MDL Number:MFCD18447678
- Synonyms:4-(2-methyl-1,3-oxazol-5-yl)benzenesulfonyl chloride;4-(2-methyloxazol-5-yl)benzene-1-sulfonyl chloride;4-(2-Methyloxazol-5-yl)benzenesulfonyl chloride;Benzenesulfonyl chloride, 4-(2-methyl-5-oxazolyl)-
3 prices
Selected condition:
Brand
- aablocks
- ChemBridge Corporation
Package
- 1g
- 5g
- Manufactureraablocks
- Product numberAA00J2FG
- Product description4-(2-methyl-1,3-oxazol-5-yl)benzenesulfonyl chloride 95%
- Packaging1g
- Price$367
- Updated2026-05-29
- Buy
- Manufactureraablocks
- Product numberAA00J2FG
- Product description4-(2-methyl-1,3-oxazol-5-yl)benzenesulfonyl chloride 95%
- Packaging5g
- Price$1467
- Updated2026-05-29
- Buy
- ManufacturerChemBridge Corporation
- Product numberBB-4043254
- Product description4-(2-methyl-1,3-oxazol-5-yl)benzenesulfonylchloride 95%
- Packaging1g
- Price$395
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| aablocks | AA00J2FG | 4-(2-methyl-1,3-oxazol-5-yl)benzenesulfonyl chloride 95% | 1g | $367 | 2026-05-29 | Buy |
| aablocks | AA00J2FG | 4-(2-methyl-1,3-oxazol-5-yl)benzenesulfonyl chloride 95% | 5g | $1467 | 2026-05-29 | Buy |
| ChemBridge Corporation | BB-4043254 | 4-(2-methyl-1,3-oxazol-5-yl)benzenesulfonylchloride 95% | 1g | $395 | 2021-12-16 | Buy |
Properties
Boiling point :384.1±25.0 °C(Predicted)
Density :1.403±0.06 g/cm3(Predicted)
pka :0.49±0.10(Predicted)
Density :1.403±0.06 g/cm3(Predicted)
pka :0.49±0.10(Predicted)
Safety Information
| Symbol(GHS): |
|
|||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal word: | Warning | |||||||||||||||||||||||||||||||||||
| Hazard statements: |
|
|||||||||||||||||||||||||||||||||||
| Precautionary statements: |
|




